SEC22 Vesicle Trafficking Protein Homolog C (S. Cerevisiae) (SEC22C) (C-Term) antibody

Antigen: SEC22 Vesicle Trafficking Protein Homolog C (S. Cerevisiae) (SEC22C)

Synonyms: MGC5373, SEC22L3, MGC13261, DKFZp761F2321, Sec22l3, 4932412K21, C530046H07, 5930407I15Rik

Epitope: C-Term

Clonality: Polyclonal

Host: Rabbit

Application: Immunohistochemistry (IHC), Western Blotting (WB)

Catalog no.: ABIN351352

Additional Information

Alternative name: Vesicle trafficking protein SEC22C (SEC22L3) (c-terminal)

Swiss-Prot: Q9BRL7

Immunogen: A synthetic from the c-terminal of human Vesicle trafficking protein SEC22C (SEC22L3) conjugated to an immunogenic carrier protein was used as the immunogen. The antigen is homologous in mouse and shares 95% identity with rat sequence.

Format: Lyophilized

Description: Function: May be involved in vesicle transport between the ER and the Golgi complex. Subcellular location: Endoplasmic reticulum membrane; Multi-pass membrane protein. Tissue specificity: Ubiquitously expressed. Also known as: SEC22L3, SEC22 vesicle-trafficking protein homolog C, SEC22 vesicle trafficking protein-like 3.

Specificity: Appears to be specific for SEC22C.

Application Details

Application Notes: IHC, WB. A dilution of 1 : 300 to 1 : 2000 is recommended. The optimal dilution should be determined by the end user. Not yet tested in other applications.

Purity: whole serum

Storage: Maintain the lyophilised/reconstituted antibodies frozen at -20°C for long term storage and refrigerated at 2-8°C for a shorter term. When reconstituting, glycerol (1:1) may be added for an additional stability. Avoid freeze and thaw cycles.

Restrictions: For Research Use only

Publications

Publications: Tang, Low, Hong: "Hsec22c: a homolog of yeast Sec22p and mammalian rsec22a and msec22b/ERS-24." in: Biochemical and biophysical research communications, Vol. 243, Issue 3, pp. 885-91, 1998 (PubMed).

Clark, Gurney, Abaya et al.: "The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment." in: Genome research, Vol. 13, Issue 10, pp. 2265-70, 2003 (PubMed).

Ota, Suzuki, Nishikawa et al.: "Complete sequencing and characterization of 21,243 full-length human cDNAs." in: Nature genetics, Vol. 36, Issue 1, pp. 40-5, 2003 (PubMed).